Elvia Cowan, SVP, Finance & CAO at Vaxcyte, Inc. (PCVX), sold 19,000 shares at $86.74 ($1.6M) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Scheduled sale ($1.6M) by SVP, Finance & CAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCVX | SELL | 2026-03-11 | $293K | — | Filing → |
| PCVX | SELL | 2025-12-29 | $1.1M | — | Filing → |
| PCVX | SELL | 2024-09-05 | $538K | — | Filing → |